RecruitingNCT06471387

Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies

Exploring the Genetic and Molecular Underpinning of Nicotine Addiction for the Development of New Therapeutic Strategies


Sponsor

University of Cyprus

Enrollment

200 participants

Start Date

Nov 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This case-control study aims to investigate the genetic and molecular bases of nicotine addiction to identify potential therapeutic targets. The project will involve drug repurposing using Mendelian Randomization, a smoking cessation intervention, and the analysis of methylation status in participants undergoing nicotine withdrawal.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria4

  • Adults aged 18-60 years old
  • Current daily cigarette smoker
  • Able to understand study procedures and provide informed consent
  • For females, non-pregnant and non-lactating

Exclusion Criteria5

  • Presence of significant uncontrolled medical conditions (e.g. cardiovascular disease, respiratory disorders, cancer) that could affect smoking behaviors or study participation
  • Presence of major uncontrolled psychiatric disorders (e.g. schizophrenia, bipolar disorder, severe depression)
  • Current substance use disorder (except nicotine dependence)
  • Taking medications that could significantly interfere with study objectives (e.g. medications for smoking cessation)
  • Significant cognitive impairment that precludes ability to complete study procedures

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFlexiquit Smoking Cessation Intervention

Participants will enter a 6-week (once weekly) self-delivered computerized intervention program called Flexiquit. Developed and validated by Clinical Psychologists of the Department of Psychology at the University of Cyprus, Flexiquit is an avatar-led app designed to support smoking cessation. It aims to assist with abstinence and monitor participants' progress through personalized modules and assessments.


Locations(1)

Center for Applied Neuroscience (CAN)

Nicosia, Cyprus

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06471387


Related Trials